Alkeran and graft versus host disease in skin Patient Reports March 21, 2010

Alkeran Side Effects Report #5034755-2
Alkeran side effect was reported by a Physician from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease in skin, mucosal inflammation. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE. Patient recovered.

Alkeran Side Effects Report #5034756-4
Alkeran side effect was reported by a Physician from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in skin, neutrophil count decreased, platelet count decreased, pneumonia . Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.

Alkeran Side Effects Report #5034757-6
Alkeran side effect was reported by a Physician from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in intestine, graft versus host disease in skin, hepatotoxicity, mucosal inflammation. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.

Alkeran Side Effects Report #5034758-8
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in skin, mucosal inflammation, platelet count decreased, sepsis . Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.


Alkeran Side Effects Report #5034759-X
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: aplasia, graft versus host disease, graft versus host disease in skin, mucosal inflammation, platelet count decreased. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.

Alkeran Side Effects Report #5034760-6
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: aplasia, graft versus host disease, graft versus host disease in skin, mucosal inflammation, platelet count decreased. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.

Alkeran Side Effects Report #5034761-8
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in skin, hepatotoxicity, pneumonia . Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYSTE IG. Patient recovered.

Alkeran Side Effects Report #5034762-X
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in intestine, graft versus host disease in skin, mucosal inflammation, pneumonia aspergillus. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.

Alkeran Side Effects Report #5035021-1
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease in intestine, graft versus host disease in skin, hepatotoxicity, mucosal inflammation, nephropathy toxic, pneumonia . Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.


Alkeran Side Effects Report #5035042-9
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in skin, hepatotoxicity, leukaemia recurrent, mucosal inflammation, pneumonia , stem cell transplant, surgical procedure repeated. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.

Alkeran Side Effects Report #5035044-2
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease in skin, mucosal inflammation. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE. Patient recovered.

Alkeran Side Effects Report #5035047-8
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in intestine, graft versus host disease in skin, mucosal inflammation. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE. Patient recovered.

Alkeran Side Effects Report #5035050-8
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease in skin, mucosal inflammation. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.

Alkeran Side Effects Report #5035056-9
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, graft versus host disease in liver, graft versus host disease in skin, infection , mucosal inflammation. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.


Alkeran Side Effects Report #5035063-6
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in skin, mucosal inflammation. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.